New Frontiers and Evolving Paradigms in Cancer and Thrombosis

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Program Medium:

Internet-based program

Method of Physician Participation Utilized in Learning Process:

There are no fees for participating and receiving CME credit for this activity. During the period December 20, 2010 through December 20, 2012 participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) register and complete the evaluation form; and 4) print out your CME certificate.

Estimated Time to Complete Educational Activity:

3.0 hours

Course Overview:

In this web-based program, physicians will learn how recent advances in basic and clinical research have helped to advance the understanding of treatment advances in the management of cancer patients at risk for thrombosis.

Release Date:

December 20, 2010

Expiration Date:

December 20, 2012

Intended Audience:

This complimentary CME educational activity is designed for specialists in thrombosis, oncology, and haemostasis who manage patients with thrombosis-related disorders.

Registration:

Enrollment for this WebCAST is complimentary, and clinicians are invited to participate in this CME-certified WebCAST and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an independent
educational grant from
Eisai, Inc.

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Massachusetts Medical School and CMEducation Resources, LLC. University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

University of Massachusetts Medical School designates this educational activity for a maximum of 3.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure:

It is the policy of University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Program Faculty and Disclosures:

Program Chairman
Samuel Z. Goldhaber, MD
Professor of Medicine
Director, Venous Thromboembolism Research Unit
Brigham and Women's Hospital
Harvard Medical School
Boston, MA

Advisor or consultant: Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, Eisai, and sanofi-aventis.
Research support: Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, Eisai, Johnson & Johnson Pharmaceutical Research & Development and sanofi-aventis


Craig Kessler, MD
Professor of Medicine
Department of Hematology
Anticoagulation Services
Georgetown University Medical Center
Washington, DC

Consultant: sanofi-aventis, Eisai
Speaker's Bureau: sanofi-aventis, Eisai


Alok A. Khorana, MD, FACP
Vice-Chief, Division of Hematology/Oncology
Associate Professor of Medicine and Oncology, James P. Wilmot Cancer Center
University of Rochester
Rochester, NY

Consultant: Sanofi-Aventis, Eisai, Leo Pharma
Speaker's Bureau: Sanofi-Aventis, Leo Pharma
Grant/Research Support: sanofi-aventis


Frederick R. Rickles, MD
Clinical Professor of Medicine, Pediatrics, Pharmacology and Physiology
Division of Hematology-Oncology
Department of Medicine
The George Washington University School of Medicine and Health Sciences
Washington, DC

Consultant: Genmab, Bayer/Ortho-McNeil/J & J, Pharmacyclics, Leo
Speaker's Bureau: Eisai

Program Managers and Web Editor Disclosure:

Program Manager Gideon Bosker, MD has nothing to disclose.

Program Reviewers Denise Leary and Richard Aghababian, MD have nothing to disclose.

Educational Objectives:

Upon Completion of this Health Management Session, Participants Should Be Able To:

• Apply current guidelines for pharmacologic prophylaxis of DVT issued by national professional organizations (ASH, ASCO, NCCN, ACCP, ASHP) in at risk patients with cancer, medical and surgical conditions.
• Risk stratify medical, oncology, and surgical patients, evaluate their likelihood for incurring DVT, and learn how to assess and implement prophylaxis measures that can reduce the incidence of DVT in these patient populations.
• Assess and manage special needs of both inpatients and discharged outpatients at risk for DVT, with a focus on long-term prophylaxis against recurrent DVT in patients with cancer, medical disorders, and in cancer patients.
• Apply landmark clinical trials focusing on DVT prevention in medical and surgical patients—in particular, those with cancer—to their clinical practice.
• Evaluate, select among, and appropriately use the range of pharmacologic options available for DVT prophylaxis, including warfarin, unfractionated heparin, and LMWHs.
• Apply current guidelines issued by national professional organizations such as NCCN and ACCP in at risk patients with medical and surgical conditions.
• Risk stratify medical and surgical oncology patients, assess their likelihood for incurring DVT, and be aware of prophylaxis measures that can reduce the incidence of DVT in patients with a variety of tumor types, and with chemotherapy.
• Assess and manage special needs of cancer and critical care patients at risk for DVT, with a focus on protecting against recurrent DVT in patients undergoing surgery
  
  

Hardware and Software Requirements:

To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to printout the CME certificate.

Privacy Policy

When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:

• We use the Information to grade your post-test and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your post-test and issue certificates of completion, we will give the Information to that company for that purpose only.
• For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
• We may use the Information to send you information about other CME activities that CMEducation Resources is offering.
• If our company is acquired by or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.
• You should check this privacy policy periodically to see whether we have made any changes.
  
  

Disclaimer:

Copyright © 2011 Resources, LLC All rights reserved.

Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.

Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2011 Resources, LLC All rights reserved.